Drug Profile
Lipopeptide vaccines - EQiTX
Alternative Names: VacTXLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator EQiTX
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders; Bacterial infections; Cancer; Hypersensitivity; Prostate cancer; Viral infections
Most Recent Events
- 21 Mar 2006 Phase-I clinical trials in Viral infections in Australia (unspecified route)
- 03 Aug 2005 This programme is available for licensing (http://www.eqitx.com)
- 03 Aug 2005 Early research in Allergy in Australia (unspecified route)